Enter your email address:

Delivered by FeedBurner

Lupin gets 5 observations from USFDA for its Vizag facility

The inspection of company's Vizag API manufacturing facility by the
United States Food and Drug Administration (USFDA) has been completed,
Lupin said in a filing to BSE. The inspection was carried out between
January 13, 2020 and January 17, 2020, it added.

The inspection for the API facility at Vizag closed with five 483
observations, Lupin said.



Post a Comment